| Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid … JC Byrd, K Mrózek, RK Dodge, AJ Carroll, CG Edwards, DC Arthur, ... Blood 100 (13), 4325-4336, 2002 | 2122 | 2002 |
| Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ... New England Journal of Medicine 371 (11), 1005-1015, 2014 | 1579 | 2014 |
| IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study G Marcucci, K Maharry, YZ Wu, MD Radmacher, K Mrózek, D Margeson, ... Journal of Clinical Oncology 28 (14), 2348-2355, 2010 | 993 | 2010 |
| Cytogenetics in acute leukemia K Mrózek, NA Heerema, CD Bloomfield Blood Reviews 18 (2), 115-136, 2004 | 987 | 2004 |
| Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B study P Paschka, G Marcucci, AS Ruppert, K Mrózek, H Chen, RA Kittles, ... Journal of Clinical Oncology 24 (24), 3904-3911, 2006 | 877 | 2006 |
| Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a Cancer … SP Whitman, KJ Archer, L Feng, C Baldus, B Becknell, BD Carlson, ... Cancer Research 61 (19), 7233-7239, 2001 | 829 | 2001 |
| Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular … K Mrózek, G Marcucci, P Paschka, SP Whitman, CD Bloomfield Blood 109 (2), 431-448, 2007 | 813 | 2007 |
| PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia Z Gu, ML Churchman, KG Roberts, I Moore, X Zhou, J Nakitandwe, ... Nature Genetics 51 (2), 296-307, 2019 | 564 | 2019 |
| Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia K Mrózek, G Marcucci, D Nicolet, KS Maharry, H Becker, SP Whitman, ... Journal of Clinical Oncology 30 (36), 4515-4523, 2012 | 551 | 2012 |
| MicroRNA expression in cytogenetically normal acute myeloid leukemia G Marcucci, MD Radmacher, K Maharry, K Mrózek, AS Ruppert, ... New England Journal of Medicine 358 (18), 1919-1928, 2008 | 547 | 2008 |
| High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in Adults KG Roberts, Z Gu, D Payne-Turner, K McCastlain, RC Harvey, IM Chen, ... Journal of Clinical Oncology 35 (4), 394-401, 2017 | 477 | 2017 |
| Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study G Marcucci, K Mrózek, AS Ruppert, K Maharry, JE Kolitz, JO Moore, ... Journal of Clinical Oncology 23 (24), 5705-5717, 2005 | 465 | 2005 |
| A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403 W Stock, SM Luger, AS Advani, J Yin, RC Harvey, CG Mullighan, ... Blood 133 (14), 1548-1559, 2019 | 449 | 2019 |
| Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene-and microRNA-expression … H Becker, G Marcucci, K Maharry, MD Radmacher, K Mrózek, ... Journal of Clinical Oncology 28 (4), 596-604, 2010 | 449 | 2010 |
| TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study KH Metzeler, K Maharry, MD Radmacher, K Mrózek, D Margeson, ... Journal of Clinical Oncology 29 (10), 1373-1381, 2011 | 437 | 2011 |
| Prospective karyotype analysis in adult acute lymphoblastic leukemia: the Cancer and Leukemia Group B experience M Wetzler, RK Dodge, K Mrózek, AJ Carroll, R Tantravahi, AMW Block, ... Blood 93 (11), 3983-3993, 1999 | 390 | 1999 |
| Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk … G Marcucci, K Maharry, MD Radmacher, K Mrózek, T Vukosavljevic, ... Journal of Clinical Oncology 26 (31), 5078-5087, 2008 | 380 | 2008 |
| Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia … SS Farag, KJ Archer, K Mrózek, AS Ruppert, AJ Carroll, JW Vardiman, ... Blood 108 (1), 63-73, 2006 | 368 | 2006 |
| Clinical significance of cytogenetics in acute myeloid leukemia. K Mrózek, K Heinonen, A de la Chapelle, CD Bloomfield Seminars in Oncology 24 (1), 17-31, 1997 | 366 | 1997 |
| ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN" favorable" genetic category KH Metzeler, H Becker, K Maharry, MD Radmacher, J Kohlschmidt, ... Blood 118 (26), 6920-6929, 2011 | 363 | 2011 |
Clara D. Bloomfield, MDThe Ohio State Universityبريد إلكتروني تم التحقق منه على osumc.edu
Andrew CarrollUniversity of Alabama at Birminghamبريد إلكتروني تم التحقق منه على uab.edu
Guido MarcucciCity of Hopeبريد إلكتروني تم التحقق منه على coh.orgKati MaharryCapricorبريد إلكتروني تم التحقق منه على capricor.com
Michael D. RadmacherBioinformatics Research Scientistبريد إلكتروني تم التحقق منه على AsterInsights.com
Peter PaschkaHaematologist/Oncologist at the Hospital of Ludwigshafen, Professor (apl.) at the University of Ulmبريد إلكتروني تم التحقق منه على klilu.de
Amy S Ruppert StarkThe Ohio State Universityبريد إلكتروني تم التحقق منه على osumc.edu
Klaus H. MetzelerUniversity Hospital Leipzig, Germanyبريد إلكتروني تم التحقق منه على klaus-metzeler.de
James S Blachly, MDAssistant Professor of Internal Medicine, The Ohio State Universityبريد إلكتروني تم التحقق منه على osumc.edu
Stefano VoliniaUniversity of Ferraraبريد إلكتروني تم التحقق منه على unife.it
Carlo CroceProfessor, Ohio State Universityبريد إلكتروني تم التحقق منه على osumc.edu
